A Randomized Controlled Study of Dendritic and Cytokine-induced Killer Cells (DC-CIK) Treatment in Patients With Hepatocellular Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dendritic cell-activated cytokine-induced killer cells (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 12 Apr 2013 Biomarkers information updated
- 09 Apr 2013 New trial record